[go: up one dir, main page]

WO2000031094A3 - Benzylglycosylamides as inhibitors of smooth muscle cell proliferation - Google Patents

Benzylglycosylamides as inhibitors of smooth muscle cell proliferation Download PDF

Info

Publication number
WO2000031094A3
WO2000031094A3 PCT/US1999/027823 US9927823W WO0031094A3 WO 2000031094 A3 WO2000031094 A3 WO 2000031094A3 US 9927823 W US9927823 W US 9927823W WO 0031094 A3 WO0031094 A3 WO 0031094A3
Authority
WO
WIPO (PCT)
Prior art keywords
cell proliferation
smooth muscle
muscle cell
inhibitors
benzylglycosylamides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/027823
Other languages
French (fr)
Other versions
WO2000031094A2 (en
Inventor
Robert Emmett Mcdevitt
Folake Oluwemimo Adebayo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Priority to AU18293/00A priority Critical patent/AU1829300A/en
Priority to CA002350755A priority patent/CA2350755A1/en
Priority to BR9915606-7A priority patent/BR9915606A/en
Priority to JP2000583922A priority patent/JP2002530419A/en
Priority to EP99961783A priority patent/EP1144426A2/en
Publication of WO2000031094A2 publication Critical patent/WO2000031094A2/en
Publication of WO2000031094A3 publication Critical patent/WO2000031094A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

This invention provides smooth muscle cell proliferation inhibitors of formula (I) having the structure (a) wherein Y is C or N; where n is 0 - 3; X is (II); or a pharmaceutically acceptable salt thereof.
PCT/US1999/027823 1998-11-24 1999-11-23 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation Ceased WO2000031094A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU18293/00A AU1829300A (en) 1998-11-24 1999-11-23 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
CA002350755A CA2350755A1 (en) 1998-11-24 1999-11-23 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
BR9915606-7A BR9915606A (en) 1998-11-24 1999-11-23 Benzylglycosylamides as inhibitors of cell proliferation in smooth muscle
JP2000583922A JP2002530419A (en) 1998-11-24 1999-11-23 Benzylglycosylamide as an inhibitor of smooth muscle cell proliferation
EP99961783A EP1144426A2 (en) 1998-11-24 1999-11-23 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19843398A 1998-11-24 1998-11-24
US09/198,433 1998-11-24

Publications (2)

Publication Number Publication Date
WO2000031094A2 WO2000031094A2 (en) 2000-06-02
WO2000031094A3 true WO2000031094A3 (en) 2000-12-21

Family

ID=22733363

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/027823 Ceased WO2000031094A2 (en) 1998-11-24 1999-11-23 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation

Country Status (7)

Country Link
EP (1) EP1144426A2 (en)
JP (1) JP2002530419A (en)
CN (1) CN1333780A (en)
AU (1) AU1829300A (en)
BR (1) BR9915606A (en)
CA (1) CA2350755A1 (en)
WO (1) WO2000031094A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9915612A (en) * 1998-11-24 2001-08-14 American Home Prod Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
US6339064B1 (en) 1998-11-24 2002-01-15 American Home Products Corporation Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
US6362170B1 (en) 1998-11-24 2002-03-26 American Home Products Corporation Benzylglycosylamides as inhibitors of smooth muscle cell proliferation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07304788A (en) * 1994-05-09 1995-11-21 Mitsui Toatsu Chem Inc Styrene derivative having oligosaccharide chain and method for producing the same
EP0714903A1 (en) * 1994-10-10 1996-06-05 Hoechst Aktiengesellschaft New carbohydrate conjugates as cell adhesion inhibitors
WO2000031093A2 (en) * 1998-11-24 2000-06-02 American Home Products Corporation Benzylglycosylamides as inhibitors of smooth muscle cell proliferation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07304788A (en) * 1994-05-09 1995-11-21 Mitsui Toatsu Chem Inc Styrene derivative having oligosaccharide chain and method for producing the same
EP0714903A1 (en) * 1994-10-10 1996-06-05 Hoechst Aktiengesellschaft New carbohydrate conjugates as cell adhesion inhibitors
WO2000031093A2 (en) * 1998-11-24 2000-06-02 American Home Products Corporation Benzylglycosylamides as inhibitors of smooth muscle cell proliferation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 199604, Derwent World Patents Index; Class A11, AN 1996-035887, XP002149382 *
DEFERRARI, JORGE O. ET AL: "Reaction of ammonia with acylated disaccharides. X. Octa-O-benzoyllactose and other benzoyl derivatives of lactose", CARBOHYD. RES. (1973), 29 (1), 141-6, XP000938501 *
NG, KEN ET AL: "Specificity of binding of.beta.-glucoside activators of ryegrass (1.fwdarw.3)-.beta.-glucan synthase and the synthesis of some potential photoaffinity activators", PLANT PHYSIOL. (1996), 111(4), 1227-1231, XP002149381 *

Also Published As

Publication number Publication date
CN1333780A (en) 2002-01-30
JP2002530419A (en) 2002-09-17
CA2350755A1 (en) 2000-06-02
EP1144426A2 (en) 2001-10-17
AU1829300A (en) 2000-06-13
BR9915606A (en) 2001-08-14
WO2000031094A2 (en) 2000-06-02

Similar Documents

Publication Publication Date Title
WO1998057937A3 (en) Inhibitors of factor xa with a neutral p1 specificity group
TR200100432T2 (en) Hepatitis C inhibitor tri-peptides
WO2001019828A3 (en) Kinase inhibitors as therapeutic agents
AU4064597A (en) Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
WO2001030781A3 (en) INHIBITORS OF αLβ2 MEDIATED CELL ADHESION
CA2348735A1 (en) Heterocyclic potassium channel inhibitors
WO2001019829A3 (en) Pyrazolopyrimidines as therapeutic agents
CA2196640A1 (en) Substituted quinazoline derivatives
CA2349330A1 (en) Nitrogen containing heterobicycles as factor xa inhibitors
WO2003048081A3 (en) Glycinamides as factor xa inhibitors
IL133623A0 (en) Antithrombotic agents
MY119820A (en) Guanidine mimics as factor xa inhibitors
WO1991019707A3 (en) Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones
CA2237189A1 (en) 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
CA2443285A1 (en) Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
WO2003053971A8 (en) Pyridoquinoxaline antivirals
AU7520898A (en) Tetrahydropyrido compounds
EP0663924A4 (en) 17-g (b) -CARBOXANILIDES OF 4-AZA-5-g (a) -ANDROSTAN-3-ONES USED AS INHIBITORS OF 5-g (a) -REDUCTASE.
WO2004030664A3 (en) New compounds for the inhibition of undesired cell proliferation and use thereof
WO2000031094A3 (en) Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
GB9923710D0 (en) Chemical compounds
EP1026162A4 (en) Antirheumatic
AU2021601A (en) Composition for the treatment of dandruff
WO2003024941A1 (en) Naphthalene compounds and use thereof as drugs
AU2002354114A1 (en) Bisimide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 99815705.8

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 2000 18293

Country of ref document: AU

Kind code of ref document: A

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1999961783

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 511069

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 18293/00

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2350755

Country of ref document: CA

Ref document number: 2350755

Country of ref document: CA

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2000 583922

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/2001/005179

Country of ref document: MX

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1999961783

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999961783

Country of ref document: EP